Acerand Therapeutics, founded by industry veterans with LAV, is focusing on the discovery and development of novel best-in-class and/or first-in-class small molecule drug candidates with robust efficacy and superior therapeutic index for the treatment of cancers. We have operations both in Shanghai, China as well as Indianapolis, US, to reflect its overall global strategy and business intents.